Our Brains Weren’t Designed for This Kind of Food
About this episode
The episode asks why obesity keeps rising and what the new weight-loss drugs reveal about it. Guyenet, a neurobiologist and author of The Hungry Brain, argues obesity is an evolutionary mismatch: brains built for food scarcity now face cheap, convenient, hyper-rewarding foods engineered to concentrate calorie and dopamine signals. Genetics strongly shape body fatness and food-reward responsiveness; experiments from cafeteria-diet rats to Kevin Hall's ultra-processed-food trials show large spontaneous overeating, while bland diets suppress intake. The brain defends a body-fat set point via leptin, making sustained loss difficult — the Biggest Loser study being an extreme illustration. Guyenet contends excess fat causally raises disease risk, citing bariatric surgery and trials where weight loss cut diabetes risk dramatically. GLP-1 drugs like semaglutide target appetite circuits directly, producing 15 percent weight loss, though pounds return when the drug stops; he notes reduced addictive behaviors and upcoming drugs like tirzepatide and oral versions.